INNOVEX INTERNATIONAL INC (INVX) Stock Fundamental Analysis

NYSE:INVX • US4576511079

25.47 USD
+0.03 (+0.12%)
At close: Feb 20, 2026
25.47 USD
0 (0%)
After Hours: 2/20/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

7

INVX gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 60 industry peers in the Energy Equipment & Services industry. INVX is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. INVX is evaluated to be cheap and growing strongly. This does not happen too often! These ratings could make INVX a good candidate for value and growth investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • INVX had positive earnings in the past year.
  • INVX had a positive operating cash flow in the past year.
  • In multiple years INVX reported negative net income over the last 5 years.
  • In multiple years INVX reported negative operating cash flow during the last 5 years.
INVX Yearly Net Income VS EBIT VS OCF VS FCFINVX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

  • INVX's Return On Assets of 8.06% is amongst the best of the industry. INVX outperforms 86.67% of its industry peers.
  • With a decent Return On Equity value of 9.73%, INVX is doing good in the industry, outperforming 70.00% of the companies in the same industry.
  • The Return On Invested Capital of INVX (8.34%) is better than 70.00% of its industry peers.
Industry RankSector Rank
ROA 8.06%
ROE 9.73%
ROIC 8.34%
ROA(3y)3.87%
ROA(5y)-0.76%
ROE(3y)4.84%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
INVX Yearly ROA, ROE, ROICINVX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

  • With an excellent Profit Margin value of 10.58%, INVX belongs to the best of the industry, outperforming 86.67% of the companies in the same industry.
  • INVX's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 12.21%, INVX is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • INVX's Operating Margin has improved in the last couple of years.
  • INVX has a Gross Margin of 32.35%. This is in the better half of the industry: INVX outperforms 71.67% of its industry peers.
  • INVX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.21%
PM (TTM) 10.58%
GM 32.35%
OM growth 3YN/A
OM growth 5Y64.81%
PM growth 3YN/A
PM growth 5Y120.24%
GM growth 3Y12.33%
GM growth 5Y4.04%
INVX Yearly Profit, Operating, Gross MarginsINVX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), INVX is destroying value.
  • The number of shares outstanding for INVX has been increased compared to 1 year ago.
  • Compared to 5 years ago, INVX has more shares outstanding
  • Compared to 1 year ago, INVX has a worse debt to assets ratio.
INVX Yearly Shares OutstandingINVX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
INVX Yearly Total Debt VS Total AssetsINVX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

  • An Altman-Z score of 6.80 indicates that INVX is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of INVX (6.80) is better than 98.33% of its industry peers.
  • The Debt to FCF ratio of INVX is 0.19, which is an excellent value as it means it would take INVX, only 0.19 years of fcf income to pay off all of its debts.
  • INVX has a Debt to FCF ratio of 0.19. This is amongst the best in the industry. INVX outperforms 93.33% of its industry peers.
  • INVX has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
  • With an excellent Debt to Equity ratio value of 0.02, INVX belongs to the best of the industry, outperforming 88.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.19
Altman-Z 6.8
ROIC/WACC0.96
WACC8.72%
INVX Yearly LT Debt VS Equity VS FCFINVX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

  • INVX has a Current Ratio of 4.78. This indicates that INVX is financially healthy and has no problem in meeting its short term obligations.
  • INVX has a better Current ratio (4.78) than 95.00% of its industry peers.
  • A Quick Ratio of 2.93 indicates that INVX has no problem at all paying its short term obligations.
  • INVX's Quick ratio of 2.93 is amongst the best of the industry. INVX outperforms 93.33% of its industry peers.
Industry RankSector Rank
Current Ratio 4.78
Quick Ratio 2.93
INVX Yearly Current Assets VS Current LiabilitesINVX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

9

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 246.15% over the past year.
  • Measured over the past years, INVX shows a very strong growth in Earnings Per Share. The EPS has been growing by 123.23% on average per year.
  • Looking at the last year, INVX shows a very strong growth in Revenue. The Revenue has grown by 47.71%.
  • INVX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.76% yearly.
EPS 1Y (TTM)246.15%
EPS 3YN/A
EPS 5Y123.23%
EPS Q2Q%170.59%
Revenue 1Y (TTM)47.71%
Revenue growth 3Y27.02%
Revenue growth 5Y9.76%
Sales Q2Q%58.09%

3.2 Future

  • The Earnings Per Share is expected to grow by 66.90% on average over the next years. This is a very strong growth
  • INVX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.31% yearly.
EPS Next Y446.5%
EPS Next 2Y160.71%
EPS Next 3Y95.77%
EPS Next 5Y66.9%
Revenue Next Year97.7%
Revenue Next 2Y43.21%
Revenue Next 3Y28.85%
Revenue Next 5Y22.31%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
INVX Yearly Revenue VS EstimatesINVX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
INVX Yearly EPS VS EstimatesINVX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • INVX is valuated quite expensively with a Price/Earnings ratio of 26.81.
  • Based on the Price/Earnings ratio, INVX is valued a bit cheaper than the industry average as 63.33% of the companies are valued more expensively.
  • INVX is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.99, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 15.62, the valuation of INVX can be described as correct.
  • Based on the Price/Forward Earnings ratio, INVX is valued cheaply inside the industry as 86.67% of the companies are valued more expensively.
  • INVX's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.06.
Industry RankSector Rank
PE 26.81
Fwd PE 15.62
INVX Price Earnings VS Forward Price EarningsINVX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • INVX's Enterprise Value to EBITDA ratio is in line with the industry average.
  • 85.00% of the companies in the same industry are more expensive than INVX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 12.43
EV/EBITDA 9.29
INVX Per share dataINVX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • INVX has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as INVX's earnings are expected to grow with 95.77% in the coming years.
PEG (NY)0.06
PEG (5Y)0.22
EPS Next 2Y160.71%
EPS Next 3Y95.77%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • INVX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INNOVEX INTERNATIONAL INC

NYSE:INVX (2/20/2026, 8:04:00 PM)

After market: 25.47 0 (0%)

25.47

+0.03 (+0.12%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)11-03
Earnings (Next)02-23
Inst Owners47.97%
Inst Owner Change3.95%
Ins Owners1.52%
Ins Owner Change-3.53%
Market Cap1.76B
Revenue(TTM)955.34M
Net Income(TTM)101.12M
Analysts77.78
Price Target25.5 (0.12%)
Short Float %N/A
Short Ratio7.33
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend1.45
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-43.31%
Min EPS beat(2)-62.53%
Max EPS beat(2)-24.08%
EPS beat(4)1
Avg EPS beat(4)-15.03%
Min EPS beat(4)-62.53%
Max EPS beat(4)49.19%
EPS beat(8)1
Avg EPS beat(8)-142.72%
EPS beat(12)2
Avg EPS beat(12)-111.91%
EPS beat(16)3
Avg EPS beat(16)-84.71%
Revenue beat(2)1
Avg Revenue beat(2)2.01%
Min Revenue beat(2)-4.42%
Max Revenue beat(2)8.43%
Revenue beat(4)3
Avg Revenue beat(4)5.34%
Min Revenue beat(4)-4.42%
Max Revenue beat(4)10.21%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)36.36%
EPS NQ rev (1m)0%
EPS NQ rev (3m)10.47%
EPS NY rev (1m)0%
EPS NY rev (3m)-11.83%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.07%
Valuation
Industry RankSector Rank
PE 26.81
Fwd PE 15.62
P/S 1.84
P/FCF 12.43
P/OCF 10.03
P/B 1.69
P/tB 2.13
EV/EBITDA 9.29
EPS(TTM)0.95
EY3.73%
EPS(NY)1.63
Fwd EY6.4%
FCF(TTM)2.05
FCFY8.04%
OCF(TTM)2.54
OCFY9.97%
SpS13.86
BVpS15.07
TBVpS11.94
PEG (NY)0.06
PEG (5Y)0.22
Graham Number17.95
Profitability
Industry RankSector Rank
ROA 8.06%
ROE 9.73%
ROCE 10.56%
ROIC 8.34%
ROICexc 9.79%
ROICexgc 12.7%
OM 12.21%
PM (TTM) 10.58%
GM 32.35%
FCFM 14.78%
ROA(3y)3.87%
ROA(5y)-0.76%
ROE(3y)4.84%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y74.94%
ROICexc growth 3YN/A
ROICexc growth 5Y70.29%
OM growth 3YN/A
OM growth 5Y64.81%
PM growth 3YN/A
PM growth 5Y120.24%
GM growth 3Y12.33%
GM growth 5Y4.04%
F-Score7
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.19
Debt/EBITDA 0.12
Cap/Depr 59.02%
Cap/Sales 3.54%
Interest Coverage 80.3
Cash Conversion 100.59%
Profit Quality 139.63%
Current Ratio 4.78
Quick Ratio 2.93
Altman-Z 6.8
F-Score7
WACC8.72%
ROIC/WACC0.96
Cap/Depr(3y)71.76%
Cap/Depr(5y)56.98%
Cap/Sales(3y)4.99%
Cap/Sales(5y)4.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)246.15%
EPS 3YN/A
EPS 5Y123.23%
EPS Q2Q%170.59%
EPS Next Y446.5%
EPS Next 2Y160.71%
EPS Next 3Y95.77%
EPS Next 5Y66.9%
Revenue 1Y (TTM)47.71%
Revenue growth 3Y27.02%
Revenue growth 5Y9.76%
Sales Q2Q%58.09%
Revenue Next Year97.7%
Revenue Next 2Y43.21%
Revenue Next 3Y28.85%
Revenue Next 5Y22.31%
EBIT growth 1Y95.65%
EBIT growth 3YN/A
EBIT growth 5Y80.9%
EBIT Next Year100.38%
EBIT Next 3Y37.48%
EBIT Next 5Y29.59%
FCF growth 1Y326.98%
FCF growth 3Y41.07%
FCF growth 5Y90.29%
OCF growth 1Y586.06%
OCF growth 3Y34.47%
OCF growth 5Y44.76%

INNOVEX INTERNATIONAL INC / INVX FAQ

Can you provide the ChartMill fundamental rating for INNOVEX INTERNATIONAL INC?

ChartMill assigns a fundamental rating of 7 / 10 to INVX.


Can you provide the valuation status for INNOVEX INTERNATIONAL INC?

ChartMill assigns a valuation rating of 7 / 10 to INNOVEX INTERNATIONAL INC (INVX). This can be considered as Undervalued.


What is the profitability of INVX stock?

INNOVEX INTERNATIONAL INC (INVX) has a profitability rating of 6 / 10.


How financially healthy is INNOVEX INTERNATIONAL INC?

The financial health rating of INNOVEX INTERNATIONAL INC (INVX) is 8 / 10.


Can you provide the dividend sustainability for INVX stock?

The dividend rating of INNOVEX INTERNATIONAL INC (INVX) is 0 / 10 and the dividend payout ratio is 0%.